Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 1 min read | 11.12.26
Crowell Authors U.S. Chapters for Global Legal Post’s Mining Law Comparative Guide
November 12, 2026: Crowell & Moring’s John J. Koenigsknecht, David S. Stone, Elaine Taussig, Ryan Flynn, and Christian Lichtenberger have authored the U.S. “Market Insights” and U.S. “Country Q&A” chapters of the inaugural edition of the Global Legal Post’s Mining Law Comparative Guide. The guide provides practical insight into the legal and regulatory frameworks governing mining across jurisdictions globally, including North America, South America, Africa, and Asia, and will be distributed on a worldwide basis.
Firm News | 2 min read | 11.11.26
Ryan Nowicki Joins Crowell & Moring’s Tax Group in Los Angeles
Firm News | 2 min read | 11.05.26
Crowell & Moring Recognized Nationally in 18 Practice Areas in 2027 Best Law Firms
